# Kiyoshi Ando

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kiyoshi-ando/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,078 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 59 |
| i10-index | 235 |
| Last Known Institution | Hiroshima University |
| OpenAlex ID | https://openalex.org/A5103757378 |
| ORCID iD | 0000-0002-5153-8850 |
| Works | 541 |

## Researcher papers

- [Obinutuzumab for the First-Line Treatment of Follicular Lymphoma](https://scholariq.org/papers/obinutuzumab-for-the-first-line-treatment-of-follicular-lymphoma/)
- [Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial](https://scholariq.org/papers/brentuximab-vedotin-with-chemotherapy-for-cd30-positive-peripheral-t-cell/)
- [Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction](https://scholariq.org/papers/nonhematopoietic-mesenchymal-stem-cells-can-be-mobilized-and-differentiate-into/)
- [Exhaustion of nucleus pulposus progenitor cells with ageing and degeneration of the intervertebral disc](https://scholariq.org/papers/exhaustion-of-nucleus-pulposus-progenitor-cells-with-ageing-and-degeneration-of/)
- [Genetic Variants in C5 and Poor Response to Eculizumab](https://scholariq.org/papers/genetic-variants-in-c5-and-poor-response-to-eculizumab/)
- [Transplantation of mesenchymal stem cells embedded in Atelocollagen® gel to the intervertebral disc: a potential therapeutic model for disc degeneration](https://scholariq.org/papers/transplantation-of-mesenchymal-stem-cells-embedded-in-atelocollagen-gel-to-the/)
- [Delta-like 4 is indispensable in thymic environment specific for T cell development](https://scholariq.org/papers/delta-like-4-is-indispensable-in-thymic-environment-specific-for-t-cell/)
- [Regenerative effects of transplanting mesenchymal stem cells embedded in atelocollagen to the degenerated intervertebral disc](https://scholariq.org/papers/regenerative-effects-of-transplanting-mesenchymal-stem-cells-embedded-in/)
- [Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma](https://scholariq.org/papers/rituximab-plus-lenalidomide-in-advanced-untreated-follicular-lymphoma/)
- [Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma](https://scholariq.org/papers/multicenter-phase-ii-study-of-mogamulizumab-kw-0761-a-defucosylated-anti-cc/)
- [Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial](https://scholariq.org/papers/safety-and-efficacy-of-the-terminal-complement-inhibitor-eculizumab-in-japanese/)
- [Long-term efficacy and safety of eculizumab in Japanese patients with PNH: AEGIS trial](https://scholariq.org/papers/long-term-efficacy-and-safety-of-eculizumab-in-japanese-patients-with-pnh-aegis/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Researcher university

- [Hiroshima University](https://scholariq.org/institutions/hiroshima-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.